These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17044564)

  • 1. Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke.
    Mocco J; Mack WJ; Ducruet AF; King RG; Sughrue ME; Coon AL; Sosunov SA; Sciacca RR; Zhang Y; Marsh HC; Pinsky DJ; Connolly ES
    J Neurosurg; 2006 Oct; 105(4):595-601. PubMed ID: 17044564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical evaluation of an sLe x-glycosylated complement inhibitory protein in a non-human primate model of reperfused stroke.
    Ducruet AF; Mocco J; Mack WJ; Coon AL; Marsh HC; Pinsky DJ; Hickman ZL; Kim GH; Connolly ES
    J Med Primatol; 2007 Dec; 36(6):375-80. PubMed ID: 17976043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of the SCR1-3 functional domain of CR1 on acute cerebral ischemia and reperfusion injury in rats.
    Yang S; Wang X; Zhang X; Lu Y; Wang Z
    Neurol Res; 2013 Nov; 35(9):976-83. PubMed ID: 23815859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effect of SCR(15-18) on cerebral ischemia-reperfusion injury.
    Li S; Xian J; He L; Luo X; Tan B; Yang Y; Liu G; Wang Z
    Neurol Res; 2011 Oct; 33(8):866-74. PubMed ID: 22004711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
    Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
    J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine.
    Eror AT; Stojadinovic A; Starnes BW; Makrides SC; Tsokos GC; Shea-Donohue T
    Clin Immunol; 1999 Feb; 90(2):266-75. PubMed ID: 10080839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
    Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
    J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved functional neurological examination for use in nonhuman primate studies of focal reperfused cerebral ischemia.
    Mack WJ; King RG; Hoh DJ; Coon AL; Ducruet AF; Huang J; Mocco J; Winfree CJ; D'Ambrosio AL; Nair MN; Sciacca RR; Connolly ES
    Neurol Res; 2003 Apr; 25(3):280-4. PubMed ID: 12739238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats.
    Yasuda N; Ishii T; Oyama D; Fukuta T; Agato Y; Sato A; Shimizu K; Asai T; Asakawa T; Kan T; Yamada S; Ohizumi Y; Oku N
    Brain Res; 2014 Apr; 1559():46-54. PubMed ID: 24534366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorative effects of Gualou Guizhi decoction on inflammation in focal cerebral ischemic-reperfusion injury.
    Zhang Y; Zhang S; Li H; Huang M; Xu W; Chu K; Chen L; Chen X
    Mol Med Rep; 2015 Jul; 12(1):988-94. PubMed ID: 25815894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.
    Huang J; Kim LJ; Mealey R; Marsh HC; Zhang Y; Tenner AJ; Connolly ES; Pinsky DJ
    Science; 1999 Jul; 285(5427):595-9. PubMed ID: 10417391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser Doppler flowmetry in non-human primate stroke studies: model refinement for pre-clinical development of cerebroprotective strategies.
    Winfree CJ; Mack WJ; Hoh D; King R; Ducruet AF; D'Ambrosio AL; Sughrue ME; McKinnell J; Connolly ES
    Acta Neurochir (Wien); 2003 Dec; 145(12):1105-10; discussion 1110. PubMed ID: 14663568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
    Pemberton M; Anderson G; Vĕtvicka V; Justus DE; Ross GD
    J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
    J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel rodent model of reperfusion injury following occlusion of the middle cerebral artery.
    Connell BJ; Saleh TM
    J Neurosci Methods; 2010 Jun; 190(1):28-33. PubMed ID: 20435065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
    Sayeed I; Guo Q; Hoffman SW; Stein DG
    Ann Emerg Med; 2006 Apr; 47(4):381-9. PubMed ID: 16546625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
    Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.
    De Simoni MG; Rossi E; Storini C; Pizzimenti S; Echart C; Bergamaschini L
    Am J Pathol; 2004 May; 164(5):1857-63. PubMed ID: 15111332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke.
    Mocco J; Choudhri T; Huang J; Harfeldt E; Efros L; Klingbeil C; Vexler V; Hall W; Zhang Y; Mack W; Popilskis S; Pinsky DJ; Connolly ES
    Circ Res; 2002 Nov; 91(10):907-14. PubMed ID: 12433835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The administration of complement component C9 augments post-ischemic cerebral infarction volume in neonatal rats.
    Imm MD; Feldhoff PW; Feldhoff RC; Lassiter HA
    Neurosci Lett; 2002 Jun; 325(3):175-8. PubMed ID: 12044649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.